Skip to main content
. 2020 May 11;12:55. doi: 10.1186/s13195-020-00621-6

Fig. 1.

Fig. 1

Study demographics and ATN biomarker profiles at baseline and follow-up. The analyses included 262 non-demented elderly individuals, with baseline and follow-up data of CSF Aβ42, p-tau, and FDG-PET metabolism, with seven different ATN biomarker profiles based on ATN classification. During the follow-up period of 6 to 120 months, the detailed process of the changes in ATN biomarker profiles in these individuals from the ADNI cohort was shown